Global Markets Direct’s latest narcolepsy report is now available for sale. You may want to purchase “Narcolepsy – Pipeline Review, H2 2013” so you can better understand diverse types of therapeutics under development for the sleep disorder. According to Global Markets Direct, you may also find this report useful to: identify emerging players and design effective counter-strategies; plan mergers and acquisitions; devise corrective measures for pipeline projects; develop and design in-licensing and out-licensing strategies by identifying prospective partners; and modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from the pipeline.
The report provides an overview of the indication’s therapeutic pipeline, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for narcolepsy.
Get more information or purchase the report here.